Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in 'MEN 2A with CLA', one of four variants of MEN 2A, which was strictly located in the scapular region of the upper back. 30049837

2018

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. 24893135

2014

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE Penetrance of inherited medullary thyroid carcinoma and genotype-phenotype correlation in a large multiple endocrine neoplasia type 2A family with C634Y RET mutation. 12746565

2003

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT A duplication of 12 bp in the critical cysteine rich domain of the RET proto-oncogene results in a distinct phenotype of multiple endocrine neoplasia type 2A. 9097963

1997

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. 8099202

1993

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene. 10522989

1999

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. 25394175

2015

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Guidelines for diagnosis and therapy of MEN type 1 and type 2. 11739416

2001

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE Comprehensive analysis of RET gene should be performed in patients with multiple endocrine neoplasia type 2 (MEN 2) syndrome and no apparent genotype-phenotype correlation: an appraisal of p.Y791F and p.C634Y RET mutations in five unrelated Brazilian families. 23723040

2013

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE The novel variants K666E, IVS9-11G-->A, D631V in cis with H665Q, D631E (with C634Y), E623K (in trans with C618S), 616delGAG (in trans with C609Y), Y606C, C630R, and R635-T636insELCR;T636P were detected in patients with various clinical presentations ranging from thyroid goiter, medullary thyroid carcinoma, and pheochromocytoma to classic multiple endocrine neoplasia type 2A. 15858153

2005

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. 23788249

2013

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Diagnosis of multiple endocrine neoplasia [MEN] 2A, 2B and familial medullary thyroid cancer [FMTC] by multiplex PCR and heteroduplex analyses of RET proto-oncogene mutations. 8807338

1996

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome. 15592804

2005

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE We have identified a mutation in codon 620, 2053 T-->C (Cys620Arg), and two mutations in codon 634 of exon 11 of RET, 2095 T-->C (Cys634Arg) and 2096 G-->A (Cys634Tyr), all three of which were present in both MEN2A and FMTC families. 7835899

1994

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE The mutation found in the RET proto-oncogene responsible for MEN2A in pediatric patients in the south of Spain is the C635Y. 24643705

2014

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Mutations of the ret protooncogene in German multiple endocrine neoplasia families: relation between genotype and phenotype. German Medullary Thyroid Carcinoma Study Group. 8626834

1996

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. 8918855

1996

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
A 0.900 GeneticVariation CLINVAR RET activation by germline MEN2A and MEN2B mutations. 8570194

1995

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT RET proto-oncogene mutations in French MEN 2A and FMTC families. 7874109

1994

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE A cys634-->tyr missense mutation, already reported as causative in MEN2A patients, was identified after SSCP analysis and direct sequencing of exon 11 of the RET protooncogene in one individual affected with both MEN2A and CLA, thus suggesting a common etiology for the two disorders. 7914213

1994

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Duplication of 9 base pairs in the critical cysteine-rich domain of the RET proto-oncogene causes multiple endocrine neoplasia type 2A. 9452064

1998

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests. 7915165

1994

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation BEFREE Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in ‘MEN 2A with CLA’, one of four variants of MEN 2A, which was strictly located in the scapular region of the upper back. 30300539

2018

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene. 7881414

1994

dbSNP: rs75996173
rs75996173
RET
Multiple Endocrine Neoplasia Type 2a
0.900 GeneticVariation UNIPROT Germline mutations of the RET proto-oncogene in eight Japanese patients with multiple endocrine neoplasia type 2A (MEN2A). 7860065

1995